State Medicaid DUR Board Meeting - Revision 5
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Drug Utilization Review Board
Notice Information
- Notice Title
- State Medicaid DUR Board Meeting
- Notice Tags
- Medicaid, Pharmacies
- Notice Type(s)
- Meeting
- Event Start Date & Time
- April 10, 2025 07:15 AM
- Event End Date & Time
- April 10, 2025 08:30 AM
- Event Deadline Date & Time
- 04/10/25 08:30 AM
- Description/Agenda
- Drug Utilization Review Board Meeting Agenda Thursday, April 10, 2025 7:15 am to 8:30 am Google Meet Joining Info Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the DUR Board may contact Ngan Huynh at (nganhuynh@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order- Sharon M. Weinstein, MD a) Welcome and Introductions - Sharon M. Weinstein, MD Housekeeping Staff Update - Sepideh Daeery, PharmD b) Review and Approval of Minutes - Sharon M. Weinstein, MD 2) P&T Update - Ngan Huynh, PharmD 3) Review a) Alyftrek & Other CTFF Modulators for Cystic Fibrosis Review - Lauren Heath, PharmD i) Public Comment ii) Committee Discussions/Questions iii) Committee Action b) CF Modulators Prior Authorization - Ngan Huynh, PharmD i) Committee Discussion/Questions ii) Committee Action c) Skyclarys (Omaveloxolone) Prior Authorization d) Zepbound - (tirzepatide) - Luis Moreno, PharmD i) Committee Questions/Discussion ii) Committee Action 4) Next Meeting a) May 8, 2025 - Alhemo for Hemophilia and Zyntego Prior Authorization 5) Adjourned 4) Review - Antipsychotics Used in Adults (Cont) a) Antipsychotics used in Adults (Cont).. .. .....University of Utah DRRC i) Public Comment (1) Alkermes - Lybalvi .. .Kenneth Berry, PharmD ii) Committee Discussion/Questions b) Rezdiffra (resmetirom) Prior Authorization Ngan Huynh, PharmD i) Committee Discussion/Questions c) Berinert, Firazyr, Kalbitor, Ruconest Prior Authorization .. Ngan Huynh, PharmD i) Committee Discussion/Questions 5) Next Meeting a) November 14, 2024. .. .Multiple Prior Authorizations Review 6) Adjourned
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
- Notice of Electronic or Telephone Participation
- Persons who wish to address the DUR Board may contact Ngan Huynh at (nganhuynh@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order . Eric Cannon, PharmD a) Announce Quorum 2) Welcome and Introductions .Eric Cannon, PharmD a) Review and Approval of Minutes b) Housekeeping 3) P&T Update .. .Bryan Larson, PharmD 4) Review a) Antipsychotics used in Adults (Cont).. .. .....University of Utah DRRC i) Public Comment (1) Alkermes - Lybalvi .. .Kenneth Berry, PharmD ii) Committee Discussion/Questions b) Rezdiffra (resmetirom) Prior Authorization Ngan Huynh, PharmD i) Committee Discussion/Questions c) Berinert, Firazyr, Kalbitor, Ruconest Prior Authorization .. Ngan Huynh, PharmD i) Committee Discussion/Questions 5) Next Meeting a) November 14, 2024. .. .Multiple Prior Authorizations Review 6) Adjourned
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Luis Moreno
- Contact Email
- lmoreno@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- March 27, 2025 08:11 PM
- Notice Last Edited On
- March 27, 2025 08:55 PM
- Deadline Date
- April 10, 2025 08:30 AM